ALD-ALLY
Alcohol-associated Liver Disease patients deserve ALcohol LiteracY
Friday, April 4, 2025
7:00–7:30 AM
Breakfast & Registration
7:30–7:45 AM
Program Overview
Gene Im, MD, FAASLD
SESSION I: Alcohol Care in Action
Moderators: Gene Im, MD and Akhil Shenoy, MD
7:45–8:00 AM
Personalizing Medications for AUD
Lamia Haque, MD, MPH
8:00–8:15 AM
Optimizing Treatment of AUD in ALD
Akhil Shenoy, MD
8:15–8:30 AM
Advocating for Institutional Change in AUD/ALD
Jessica Mellinger, MD
8:30–8:45 AM
Navigating the Waters of Alcohol Care: Clinician Burnout, Interprofessional Relationships, & Center Culture
Gerald S. Winder, MD, MSc, FACLP
8:45–9:15 AM
Panel Discussion
9:15-9:45 AM
Alcohol Debate #1: MAUD Should Be Prescribed For Every Patient with AUD
Pro: Gerald S. Winder, MD, MSc, FACLP
Con: Akhil Shenoy, MD
.
9:45–10:00 AM
Break/Exhibit Hall
SESSION II: Advances in ALD Care
Moderators: Jessica Mellinger, MD and Sumeet Asrani, MD, MSc
10:00-10:15 AM
Early Detection Strategies for ALD
Marina Serper, MD, MS
10:15-10:30 AM
Strategies To Improve ALD Care At Your Center
Shari Rogal, MD, MPH
10:30-10:45 AM
High Impact Studies in ALD — Year in Review
Juan Pablo Arab, MD, FRCPC
10:45-11:00 AM
Update on Liver Transplantation for ALD
Gene Im, MD, FAASLD
11:00-11:30 AM
Panel Discussion
11:30 AM–12:00 PM
Alcohol Debate #2: LT For AH - Candidate Selection Simulation
Moderators: Gene Im, MD, FAASLD and Sumeet Asrani, MD, MSc
12:00-1:00 PM
Lunch
SESSION III: Future of ALD Care
Moderators: Juan Pablo Arab, MD, FRCPC and Rohit Loomba, MD, MHSc, FAASLD
1:00–1:15 PM
Designing Clinical Trials in AH & ALD
Alexandre Louvet, MD, PhD
1:15–1:30 PM
What Outcomes Are Important To Patients With ALD
Jenn Jones
1:30-1:45 PM
Alcohol Policies to Improve Health
Sumeet Asrani, MD, MSc
1:45-2:15 PM
Panel Discussion
2:15–2:30 PM
Break/Exhibit Hall
SESSION IV: MetALD—New Kid on the Block
Moderator: Sumeet Asrani, MD, MSc and Marina Serper, MD
2:30–2:45 PM
Defining and Refining MetALD
Gene Im, MD, FAASLD
2:45–3:00 PM
Epidemiology of MetALD
Hannes Hagström, MD, PhD
3:00–3:15 PM
Pharmacotherapy for MetALD: Are We Ready Yet?
Rohit Loomba, MD, MHSc, FAASLD
3:15–3:30 PM
MetALD Clinical Trials Design
Mazen Noureddin, MD, MHSc
3:30–4:00 PM
Panel Discussion
4:00–4:30 PM
MetALD Debate: Which is more important in treating MetALD?
Met: Mazen Noureddin, MD, MHSc
ALD: Hannes Hagström, MD, PhD
4:30 PM
Program Summary
Sumeet Asrani, MD, MSc